Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Clin Cancer Res. 2012 Jul 23;18(17):4743–4752. doi: 10.1158/1078-0432.CCR-12-0707

Figure 4.

Figure 4

Kaplan-Meier survival estimates of overall survival and time-to-recurrence in patients with duodenal adenocarcinomas. Overall survival in (A) groups classified by CIMP/MLH1 methylation status, (C) groups classified by CIMP/MSI status. Time-to-recurrence in (B) groups classified by CIMP/MLH1 methylation status, (D) groups classified by CIMP/MSI status. The P values shown have been pooled over strata.